University of Iowa Hospitals and Clinics

Clinical Trial Details

Short Title
Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
Official Title

Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I

Description

Participants in this study have been diagnosed with adenocarcinoma of the pancreas, a type of pancreatic cancer. The purpose of this study is to see if using pharmacological ascorbate and gemcitabine chemoradiation is safe and effective in treating pancreatic cancer. Approximately 30 people will take part in this study at the University of Iowa.

Start Date
January 21, 2014
End Date
October 31, 2017
Gender Preference
None
Age Group
18 - 99 years
Principal Investigator
Joseph Cullen MD
Contact Info

Sandy Vollstedt      319-356-4422

Department
GI Surgery
Keywords
Cancer ; Cullen ; Pancreatic ; phase 1 ; phase i ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.